News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Alnylam (ALNY) Rapamune Elan (ELN) Sarepta (SRPT) NANTKWEST (NK) Jazz Pharmaceuticals (JAZZ) TOKAI (TKAOI) Endometrial Cancer Xoma (XOMA) ImmunoGen (IMGN) Amgen (AMGN) Galena (GALE) Multiple Myeloma Agenus (AGEN) Bristol-Myers Squibb (BMY) Anadys (ANDS) ABBVIE (ABBV) JUNO (JUNO) Idenix (IDIX) KERYX (KERX) Prolor Biotech (PBTH) Ziofpharm (ZIOP) BIOMARIN (BMRN) Cytokinetics (CYTK) Ionis (IONS) Pluristem (PSTI) Genentech REGULUS (RGLS) Illumina (ILMN) Roche (ROCHE) OSI (OSIP) Mirati Therapeutics (MRTX) RenenxBio (RGNX) ADVENTRIX (ANX) Sanofi (SNA) Theravance (THRX) Gilead (GILD) C4 Therapeutics Intermune (ITMN) Intercept (ICPT) Vitae Pharmaceuticals (VTAE) Revlimid (lenolidamide) Theravance Bio Pharma (TBPH) Sequenom (SQNM) Inovio (INO) ISIS (ISIS) GUARDIAN HEALTH Anacor (ANAC) Roche (RHHBY) Zerenex Dendreon (DNDN) SERES THERAPEUTICS (MCRB) Intrexon (XON) Tysabri Abbott Laboratories (ABT) Micromet (MITI) Regeneron (REGN) Benlysta (belimumab) ACADIA (ACAD) KITE (KITE) Trastuzumab-DM1 VANDA (VNDA) Seattle Genetics (SGEN) SYNTA (SNTA) SUNESIS PHARMACEUTICALS (SNSS) Biogen Idec (BIIB) Human Longevity (HLI) Aimmune Therapeutics (AIMT) IDERA (IDRA) HALOZYME (HALO) ARCA (ABIO) Sanofi-Aventis (SAN) Incyte (INCY) Sanofi (SNY) Prosensa (RNA) Human Genome Sciences (HGSI) Ridaforolimus PTC Therapeutics (PTCT) CompuGen (CGEN) Velcade (bortezomib) Valeant Pharmaceuticals International (VRX) Editas (EDIT) GlaxoSmithKline (GSK) Agenus (AGEN Vertex (VRTX) Alder Biopharmaceuticals (ALDR) NEKTAR (NKTR)) Onyx (ONXX) Array Pharmaceuticals (ARRY) Biocryst (BCRX) Merck (MRK) Telaprevir galapagos (GLPG) AERIE PHARMACEUTICALS Dynavax (DVAX) Auspex (ASPX) ZALTRAP™ Sangamo (SGMO) Herceptin Exelixis (EXEL) Ariad (ARIA)